Upload Avatar (500 x 500)
Weifeng Ma
Public Health
Southern Medical University
Guangdong
Language: Chinese, English
Virus
Prevention
Treatment
Covid-19
Hiv
Nanomedicine
Cytokine Storm
Inflammation
Cancer
Antiviral
Areas of Focus
- Virus Prevention and Treatment
Publications
- Development of Cas13a-based therapy for cancer treatment, Ying Dong, Bingyang Zhang, Yi Wei, Arkady Murashev, Suihai Wang, Yingsong Wu, Weifeng Ma, Tiancai Liu, 2024
- PreS/2-21-Guided siRNA Nanoparticles Target to Inhibit Hepatitis B Virus Infection and Replication, Lixia Gao, Jie Yang, Jutao Feng, Ziying Liu, Ying Dong, Jiangyan Luo, Liangzhentian Yu, Jiamei Wang, Hongying Fan, Weifeng Ma, Tiancai Liu, 2022
- CRISPR-Cas13a-based diagnostic method for Chlamydia trachomatis from nongonococcal urethritis, Kai chen Huang, Hailing Yu, Zhenhua Chen, Guanfeng Lin, Zhigao Zhang, Xiaoyan Zhang, Ying Dong, Hong Chen, Zhen Zhang, Weifeng Ma, Yingsong Wu, Tiancai Liu, 2021
- Value of Viral Nucleic Acid in Sputum and Feces and Specific IgM/IgG in Serum for the Diagnosis of Coronavirus Disease 2019, Yuwen He, Jiangyan Luo, Jie Yang, Jinlong Song, Li Wei, Weifeng Ma, 2020
- Development of triazolothiadiazine derivatives as highly potent tubulin polymerization inhibitors: Structure-activity relationship, in vitro and in vivo study, Weifeng Ma, Peng Chen, Xiansen Huo, Yufeng Ma, Yanhong Li, Pengcheng Diao, Fang Yang, Shengquan Zheng, Mengjin Hu, Wenwei You, Peiliang Zhao, 2020
- A Novel CXCR4 Targeting Protein SDF-1/54 as an HIV-1 Entry Inhibitor, Tan S, Li W, Li Z, Li Y, Luo J, Yu L, Yang J, Qiu M, Cheng H, Xu W, Jiang S, Lu L, Liu S, Ma W, 2019
- Novel [1, 2, 4] triazolo [1, 5-a] pyrimidine derivatives as potent antitubulin agents: Design, multicomponent synthesis and antiproliferative activities, Yang F, Yu LZ, Diao PC, Jian XE, Zhou MF, Jiang CS, You WW, Ma WF, Zhao PL, 2019
Awards
- Guangzhou Pearl River Science and Technology New Star (2013)
